The Comparative Effectiveness of Monotherapy and Combination Therapies: Impact of Angiotensin Receptor Blockers on the Onset of Alzheimer’s Disease

BACKGROUND: The criteria for use of Alzheimer’s disease (AD) drug Leqembi recommended by the Department of Veterans Affairs (VA) include patients aged 65 years or older with mild cognitive impairment (MCI) or mild AD. Comorbidities that include hypertension, hyperlipidemia, and diabetes are common a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Y., Li, M., Kazis, L.E., Xia, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SERDI Publisher 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333644/
https://www.ncbi.nlm.nih.gov/pubmed/37441415
http://dx.doi.org/10.14283/jarlife.2023.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333644/
https://www.ncbi.nlm.nih.gov/pubmed/37441415
http://dx.doi.org/10.14283/jarlife.2023.8

Ejemplares similares